Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor anthracyclines prepared at Pharmacia & Upjohn

March 27, 1998

Imutec Pharma begins preclinical development of antitumor agents

March 27, 1998

Disappointing preliminary phase III results for lisofylline in BMT

March 27, 1998

FDA advisory committee recommends Taxol for new indications

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

Differentiation-inducing retinoyloxy(substituted)alkylene butyrates from Bar-Ilan

March 26, 1998

Northwest Hospital's prostate cancer vaccine shows promise in phase I/II; new trial sites added

March 26, 1998

Angiogenesis-inhibitory monokine available for licensing from NIH

March 25, 1998

New agents for PDT reported by Yeda

March 25, 1998

New antitumor agents discovered by Toagosei

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026